Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study

作者：Martin Reck, Rafał Dziadziuszko, Shunichi Sugawara, Steven C-H Kao, Maximilian Johannes Hochmair, Florian Huemer, Gilberto de Castro, Libor Havel, Reyes Bernabé Caro, György Losonczy, Jong Seok Lee, Dariusz Mirosław Kowalski, Zoran Andric, Raffaele Califano, Andrea Veatch, Gregory James Gerstner, Marta Batus, Stefanie Morris, Monika D. Kaul, Vaikunth Cuchelkar, Huafei Li, Bradford J. Danner, Barzin Y. Nabet, Stephen V. Liu · 发表于：Lung Cancer · 年份：2024 · DOI：10.1016/j.lungcan.2024.107924 · 被引用次数：81 · 研究领域：Lung Cancer Research Studies、Neuroendocrine Tumor Research Advances、Cancer Immunotherapy and Biomarkers